Published in Vaccine Weekly, December 7th, 1998
IntraVec says it has built on research done at Wake Forest University School of Medicine by Si-Yi Chen, MD, PhD, a former assistant professor of cancer biology and now an associate professor at Baylor College of Medicine.
The cancer treatments use "toxic cell" technology in which Chen and his colleagues genetically modified normal cells to produce and secrete a toxin that attacks and kills cancer cells but does not harm the carrier cell or other normal cells.
Scientists see this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.